Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Antiviral Therapy With Pegylated Interferon-alpha for Chronic Hepatitis C and B on Auditory Disability: A Prospective Study

NCT01265693 is registered in ClinicalTrials.gov with Carmel Medical Center as lead sponsor.

NCT NCT01265693
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01265693 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Antiviral Therapy With Pegylated Interferon-alpha for Chronic Hepatitis C and B on Auditory Disability: A Prospective Study
Lead sponsor
Carmel Medical Center
Phase
Observational
Overall status
Completed
Start date
January 9, 2011
Completion date
March 26, 2015
Enrollment
100 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hearing loss, sudden deafness